Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction

Area of Science:

• Cardiology
• Biochemistry
• Diagnostic Medicine

Background:

• Left ventricular (LV) dysfunction is a critical indicator of cardiac health.
• Noninvasive methods for detecting LV dysfunction are essential for patient management.
• Natriuretic peptides are investigated for their potential role in diagnosing cardiac conditions.

Purpose of the Study:

• To evaluate the predictive diagnostic value of plasma natriuretic peptide levels for identifying LV dysfunction.
• To assess the utility of natriuretic peptides, alongside clinical and electrocardiographic factors, as noninvasive indicators of cardiac dysfunction.

Main Methods:

• Measured plasma levels of various natriuretic peptides (cANP, nANP, BNP, proBNP, CNP) in 211 subjects before cardiac catheterization.
• Correlated peptide levels with LV function parameters, including LV ejection fraction (LVEF).
• Utilized receiver operating characteristic (ROC) analysis and logistic regression for diagnostic accuracy and independent predictor identification.

Main Results:

• N-terminal fragment of proANP (nANP)(80-96) showed the strongest correlation with LV function parameters.
• Elevated levels of nANP(26-55), nANP(80-96), cANP(99-126), and BNP-32 were significantly increased in patients with LVEF ≤ 45%.
• Multivariate analysis identified Q waves, bundle branch block, and elevated cANP, nANP(80-96), and nANP(26-55) as independent predictors of low ejection fractions.

Conclusions:

• Elevated nANP(80-96) and nANP(26-55) levels are strong indicators of LV dysfunction.
• These natriuretic peptides enhance the diagnostic accuracy and specificity for detecting LV dysfunction when combined with clinical and ECG factors.
• Plasma natriuretic peptide levels offer valuable information for identifying abnormal LV function in individual patients.